Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)
Status:
Completed
Trial end date:
2017-06-21
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD)
of asfotase alfa in adult participants with pediatric-onset HPP.